clarithromycin has been researched along with Johne Disease in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (11.11) | 18.2507 |
2000's | 7 (77.78) | 29.6817 |
2010's | 1 (11.11) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bertani, L; Blandizzi, C; Bodini, G; Buda, A; Ceccarelli, L; Costa, F; De Bortoli, N; Facchin, S; Lorenzon, G; Marabotto, E; Marchi, S; Savarino, E; Savarino, V; Zingone, F | 1 |
Awotesu, O; Lightman, S; Lynn, WA; Missotten, T; Pitcher, MC | 1 |
Kuenstner, JT | 1 |
Barash, DP; Lipton, JE | 1 |
Biesecker, J; Gitlin, L | 1 |
Chamberlin, W | 1 |
Barnes, N; Clarke, C; Finlayson, C; Hermon-Taylor, J | 1 |
Hermon-Taylor, J | 1 |
El-Zaatari, FA; Kugler, L; Naser, SA; Sandoval, J; Shafran, I | 1 |
2 review(s) available for clarithromycin and Johne Disease
Article | Year |
---|---|
Antimicrobial treatment with the fixed-dose antibiotic combination RHB-104 for Mycobacterium avium subspecies paratuberculosis in Crohn's disease: pharmacological and clinical implications.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Combinations; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Remission Induction; Rifabutin | 2019 |
Mycobacterium paratuberculosis cervical lymphadenitis, followed five years later by terminal ileitis similar to Crohn's disease.
Topics: Animals; Anti-Bacterial Agents; Antibiotics, Antitubercular; Child; Clarithromycin; Humans; Ileitis; Male; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Polymerase Chain Reaction; Rifabutin; Tuberculosis, Lymph Node | 1998 |
1 trial(s) available for clarithromycin and Johne Disease
Article | Year |
---|---|
Open clinical trial of rifabutin and clarithromycin therapy in Crohn's disease.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Colonoscopy; Crohn Disease; Female; Humans; Male; Middle Aged; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Remission Induction; Rifabutin; Treatment Outcome | 2002 |
6 other study(ies) available for clarithromycin and Johne Disease
Article | Year |
---|---|
Uveitis in a patient receiving rifabutin for Crohn's disease.
Topics: Adult; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Crohn Disease; Drug Therapy, Combination; Female; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Rifabutin; Tuberculosis, Ocular; Uveitis, Anterior | 2004 |
The Australian antibiotic trial in Crohn's disease: alternative conclusions from the same study.
Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Reproducibility of Results; Research Design; Rifabutin | 2007 |
Flawed Australian CD study does not end MAP controversy.
Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Rifabutin | 2007 |
Australian Crohn's antibiotic study opens new horizons.
Topics: Anti-Bacterial Agents; Antibodies, Monoclonal; Clarithromycin; Clofazimine; Crohn Disease; Drug Therapy, Combination; Gastrointestinal Agents; Humans; Infliximab; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Remission Induction; Reproducibility of Results; Rifabutin; Treatment Outcome | 2007 |
Importance of the Australian Crohn's disease antibiotic study.
Topics: Anti-Bacterial Agents; Clarithromycin; Clofazimine; Crohn Disease; Data Interpretation, Statistical; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Randomized Controlled Trials as Topic; Rifabutin; Treatment Outcome | 2007 |
Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: more evidence for a neglected public health tragedy.
Topics: Clarithromycin; Clofazimine; Crohn Disease; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Mycobacterium avium subsp. paratuberculosis; Paratuberculosis; Rifabutin; Vaccines, DNA | 2002 |